Quick Takeaways
- ACHV - ACHIEVE LIFE SCIENCES, INC. has 28 insiders with reported activity on this page.
- Net insider value flow over the last year: -$1,084,997.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 28 Insiders of ACHIEVE LIFE SCIENCES, INC.
- Symbol
- ACHV on Nasdaq
- Location
- Seattle, WA
What Changed
- Buy value: ; sell value: $1,084,996.
- Net share flow: -381,972.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$1,084,997.
Buys
$0
Shares: 0
Insiders: 0
Sells
$1,084,997
Shares: 381,972
Insiders: 6
Net
-$1,084,997
Shares: -381,972
Insiders: -6
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 381,972 | $0 | $1,084,997 | -$1,084,997 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
ACHIEVE LIFE SCIENCES, INC. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Jon Winkelried | 10%+ Owner | $20,220,085 | Median | 17 Apr 2026 | ||
| James G. Coulter | 10%+ Owner | $20,220,085 | Median | 17 Apr 2026 | ||
| TPG GP A, LLC | 10%+ Owner | $20,220,085 | Median | 17 Apr 2026 | ||
| DIALECTIC CAPITAL MANAGEMENT, LP | 10%+ Owner | $19,519,500 | Mixed | 18 Nov 2022 | ||
| Thomas B. King | Director | $2,542,793 | -$387,407 | -13% | Mixed | 04 Sep 2025 |
| Richard Alistair Stewart | Chief Executive Officer, Director | $1,250,261 | -$378,143 | -23% | Mixed | 18 Sep 2025 |
| Mark K. Oki | Chief Financial Officer | $990,144 | -$146,175 | -13% | Mixed | 18 Sep 2025 |
| Cindy Jacobs | President & CMO | $797,270 | -$76,532 | -8.8% | Mixed | 04 Sep 2025 |
| Jaime Xinos | Chief Commercial Officer | $573,176 | -$57,766 | -9.2% | Mixed | 04 Sep 2025 |
| John Bencich | CEO, Director | $369,334 | Mixed | 16 Aug 2024 | ||
| Jerry Wan | Principal Accounting Officer | $266,722 | -$38,974 | -13% | Mixed | 04 Sep 2025 |
| Mark Lawrence Rubinstein | Chief Medical Officer | $185,724 | Mixed | 01 Jan 2026 | ||
| Craig Donnelly | Chief Operations Officer | $165,495 | Mixed | 01 Oct 2025 | ||
| Anthony Clarke | Cso | $39,490 | Mixed | 28 Apr 2022 | ||
| Nancy R. Phelan | Director | Mixed | 06 Jun 2025 | |||
| SVB FINANCIAL GROUP | 10%+ Owner | Mixed | 18 Nov 2022 | |||
| Vaughn B. Himes | Director | Mixed | 22 Jan 2024 | |||
| Bridget A. Martell | Director | Mixed | 06 Jun 2025 | |||
| Kristen B. Slaoui | Director | Mixed | 06 Jun 2025 | |||
| Thomas Sellig | Director | Mixed | 06 Jun 2025 | |||
| Erik Atkisson | Chief Legal Officer | Mixed | 04 Dec 2025 | |||
| Donald Joseph | Director | Mixed | 31 May 2022 | |||
| Andrew D. Goldberg | CEO and President, Director | Mixed | 18 Apr 2026 | |||
| Lucian Iancovici | Director | Mixed | 17 Apr 2026 | |||
| Martin A. Mattingly | Director | Mixed | 31 May 2022 | |||
| Jay M. Moyes | Director | Mixed | 31 May 2022 | |||
| Stuart Duty | Director | Mixed | 06 Jun 2025 | |||
| Aaron Royston | Director | Mixed | 17 Apr 2026 |
Top shareholders of ACHIEVE LIFE SCIENCES, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TPG GP A, LLC |
13D/G
3/4/5
|
10%+ Owner |
13%
|
13,755,160
|
$40,440,170 | $0 | 17 Apr 2025 | |
| FRANKLIN RESOURCES INC |
13D/G
13F
|
Company |
12%
|
6,369,193
|
$31,654,889 | -$11,286,105 | 31 Dec 2025 | |
| venBio Global Strategic Fund V, L.P. |
13D/G
|
— |
10%
|
10,737,317
|
$31,567,712 | $0 | 15 Apr 2026 | |
| Paradigm Biocapital Advisors LP |
13D/G
|
— |
9.2%
|
9,903,712
|
$29,116,913 | $0 | 17 Apr 2026 | |
| James G. Coulter |
3/4/5
|
10%+ Owner |
6.4%
|
6,877,580
|
$20,220,085 | — | 17 Apr 2026 | |
| Jon Winkelried |
3/4/5
|
10%+ Owner |
6.4%
|
6,877,580
|
$20,220,085 | — | 17 Apr 2026 | |
| DIALECTIC CAPITAL MANAGEMENT, LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,549,000
|
$19,519,500 | — | 18 Nov 2022 | |
| Frazier Life Sciences Public Fund, L.P. |
13D/G
|
— |
6.5%
|
6,625,788
|
$19,479,817 | $0 | 17 Apr 2026 | |
| Propel Bio Management, LLC |
13F
|
Company |
3.5%
|
3,786,425
|
$18,818,532 | — | 31 Dec 2025 | |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
— |
5.2%
|
5,502,064
|
$16,176,068 | $0 | 17 Apr 2026 | |
| VANGUARD GROUP INC |
13F
13D/G
|
Company · The Vanguard Group |
5%
from 13D/G
|
2,474,312
|
$12,297,331 | — | 31 Dec 2025 | |
| Alyeska Investment Group, L.P. |
13D/G
|
— |
5.6%
|
2,982,722
|
$9,395,574 | -$6,098,715 | 30 Sep 2025 | |
| Contrarian Alpha, LP |
13D/G
|
Parker Quillen |
4.9%
|
2,528,377
|
$7,964,388 | $0 | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,359,116
|
$6,754,807 | — | 31 Dec 2025 | |
| Simplify Asset Management Inc. |
13F
|
Company |
1.1%
|
1,184,512
|
$5,887,025 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.95%
|
1,019,281
|
$5,065,825 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.7%
|
748,616
|
$3,720,622 | — | 31 Dec 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.6%
|
648,885
|
$3,224,958 | — | 31 Dec 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.59%
|
633,148
|
$3,146,746 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.56%
|
599,611
|
$2,981,591 | — | 31 Dec 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.56%
|
599,679
|
$2,980,404 | — | 31 Dec 2025 | |
| Thomas B. King |
3/4/5
|
Director |
—
mixed-class rows
|
346,642
mixed-class rows
|
$2,542,793 | -$387,407 | 04 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.46%
|
496,350
|
$2,466,859 | — | 31 Dec 2025 | |
| KVP Capital Advisors, LP |
13F
|
Company |
0.43%
|
462,355
|
$2,297,904 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.42%
|
450,928
|
$2,241,112 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
0.6%
from 13D/G
|
419,133
|
$2,083,091 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.36%
|
382,211
|
$1,899,588 | — | 31 Dec 2025 | |
| Pathstone Holdings, LLC |
13F
|
Company |
0.39%
|
416,667
|
$1,858,335 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.27%
|
285,229
|
$1,417,588 | — | 31 Dec 2025 | |
| Richard Alistair Stewart |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
875,116
mixed-class rows
|
$1,250,261 | -$378,143 | 18 Sep 2025 | |
| Shay Capital LLC |
13F
|
Company |
0.22%
|
234,937
|
$1,167,637 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.22%
|
234,257
|
$1,164,257 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.21%
|
229,879
|
$1,142,499 | — | 31 Dec 2025 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.2%
|
214,897
|
$1,068,038 | — | 31 Dec 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.2%
|
209,900
|
$1,043,203 | — | 31 Dec 2025 | |
| Mark K. Oki |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
307,940
mixed-class rows
|
$990,144 | -$146,175 | 18 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.16%
|
167,945
|
$834,687 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.15%
|
164,605
|
$818,087 | — | 31 Dec 2025 | |
| Cindy Jacobs |
3/4/5
|
President & CMO |
—
mixed-class rows
|
219,585
mixed-class rows
|
$797,270 | -$76,532 | 04 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.14%
|
152,460
|
$757,726 | — | 31 Dec 2025 | |
| Jaime Xinos |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
334,432
mixed-class rows
|
$573,176 | -$57,766 | 04 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.1%
|
110,032
|
$546,859 | — | 31 Dec 2025 | |
| Blue Trust, Inc. |
13F
|
Company |
0.08%
|
85,888
|
$426,863 | — | 31 Dec 2025 | |
| Alpine Global Management, LLC |
13F
|
Company |
0.08%
|
83,481
|
$414,901 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
79,061
|
$392,933 | — | 31 Dec 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.07%
|
75,169
|
$373,590 | — | 31 Dec 2025 | |
| John Bencich |
3/4/5
|
CEO, Director |
—
mixed-class rows
|
185,636
mixed-class rows
|
$369,334 | — | 16 Aug 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.07%
|
70,059
|
$348,193 | — | 31 Dec 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.06%
|
67,663
|
$336,285 | — | 31 Dec 2025 | |
| MANCHESTER FINANCIAL INC |
13F
|
Company |
0.05%
|
59,084
|
$293,648 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for ACHIEVE LIFE SCIENCES, INC.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Andrew D. Goldberg | ACHV | Performance Restricted Stock Unit (PRSU) | Award | 11,706,270 | 11,706,270 | 18 Apr 2026 | Direct | |||
| Andrew D. Goldberg | ACHV | Stock Option (right to buy) | Award | 3,601,929 | 3,601,929 | 18 Apr 2026 | Direct | |||
| Andrew D. Goldberg | ACHV | Restricted Stock Unit (RSU) | Award | 1,800,965 | 1,800,965 | 18 Apr 2026 | Direct | |||
| Mark Lawrence Rubinstein | ACHV | Stock Option (right to buy) | Award | 180,000 | 180,000 | 28 Jan 2026 | Direct | |||
| Craig Donnelly | ACHV | Stock Option (right to buy) | Award | 180,000 | 180,000 | 28 Jan 2026 | Direct | |||
| Jaime Xinos | ACHV | Stock Option (right to buy) | Award | 180,000 | 180,000 | 28 Jan 2026 | Direct | |||
| Jerry Wan | ACHV | Stock Option (right to buy) | Award | 70,300 | 70,300 | 28 Jan 2026 | Direct | |||
| Richard Alistair Stewart | ACHV | Stock Option (right to buy) | Award | 645,000 | 645,000 | 28 Jan 2026 | Direct | |||
| Mark K. Oki | ACHV | Stock Option (right to buy) | Award | 180,000 | 180,000 | 28 Jan 2026 | Direct | |||
| Erik Atkisson | ACHV | Stock Option (right to buy) | Award | 250,000 | 250,000 | 04 Dec 2025 | Direct | |||
| Craig Donnelly | ACHV | Stock Option (right to buy) | Award | 50,000 | 50,000 | 01 Oct 2025 | Direct | |||
| Mark K. Oki | ACHV | Common Stock | Sale | -28.1% | $146,175 | $2.92 | -50,060 | 127,940 | 18 Sep 2025 | Direct |
| Mark K. Oki | ACHV | Common Stock | Options Exercise | 1680% | 168,000 | 178,000 | 18 Sep 2025 | Direct | ||
| Mark K. Oki | ACHV | Performance Restricted Stock Unit (PRSU) | Options Exercise | -100% | -168,000 | 0 | 18 Sep 2025 | Direct | ||
| Richard Alistair Stewart | ACHV | Common Stock | Sale | -36.1% | $378,143 | $2.92 | -129,501 | 228,875 | 18 Sep 2025 | Direct |
| Richard Alistair Stewart | ACHV | Common Stock | Options Exercise | 488.7% | 297,500 | 358,376 | 18 Sep 2025 | Direct | ||
| Richard Alistair Stewart | ACHV | Performance Restricted Stock Unit (PRSU) | Options Exercise | -100% | -297,500 | 0 | 18 Sep 2025 | Direct | ||
| Mark K. Oki | ACHV | Performance Restricted Stock Unit | Award | -100% | -168,000 | 0 | 04 Sep 2025 | Direct | ||
| Richard Alistair Stewart | ACHV | Performance Restricted Stock Unit | Award | -100% | -297,500 | 0 | 04 Sep 2025 | Direct | ||
| Jerry Wan | ACHV | Common Stock | Sale | -30.1% | $38,974 | $2.77 | -14,070 | 32,694 | 04 Sep 2025 | Direct |
| Jerry Wan | ACHV | Common Stock | Options Exercise | 269.3% | 34,100 | 46,764 | 04 Sep 2025 | Direct | ||
| Jerry Wan | ACHV | Performance Restricted Stock Unit (PRSU) | Options Exercise | -100% | -34,100 | 0 | 04 Sep 2025 | Direct | ||
| Thomas B. King | ACHV | Common Stock | Sale | -30.7% | $387,407 | $2.77 | -139,858 | 315,142 | 04 Sep 2025 | Direct |
| Thomas B. King | ACHV | Common Stock | Options Exercise | 455,000 | 455,000 | 04 Sep 2025 | Direct | |||
| Thomas B. King | ACHV | Performance Restricted Stock Unit (PRSU) | Options Exercise | -100% | -455,000 | 0 | 04 Sep 2025 | Direct | ||
| Cindy Jacobs | ACHV | Common Stock | Sale | -19.3% | $76,532 | $2.77 | -27,629 | 115,585 | 04 Sep 2025 | Direct |
| Cindy Jacobs | ACHV | Common Stock | Options Exercise | 331.2% | 110,000 | 143,214 | 04 Sep 2025 | Direct | ||
| Cindy Jacobs | ACHV | Performance Restricted Stock Unit (PRSU) | Options Exercise | -100% | -110,000 | 0 | 04 Sep 2025 | Direct | ||
| Jaime Xinos | ACHV | Common Stock | Sale | -21.9% | $57,766 | $2.77 | -20,854 | 74,432 | 04 Sep 2025 | Direct |
| Jaime Xinos | ACHV | Common Stock | Options Exercise | 262.5% | 69,000 | 95,286 | 04 Sep 2025 | Direct | ||
| Jaime Xinos | ACHV | Performance Restricted Stock Unit (PRSU) | Options Exercise | -100% | -69,000 | 0 | 04 Sep 2025 | Direct | ||
| Kristen B. Slaoui | ACHV | Stock Option (right to buy) | Award | 31,500 | 31,500 | 06 Jun 2025 | Direct | |||
| Nancy R. Phelan | ACHV | Stock Option (right to buy) | Award | 31,500 | 31,500 | 06 Jun 2025 | Direct | |||
| Thomas Sellig | ACHV | Stock Option (right to buy) | Award | 31,500 | 31,500 | 06 Jun 2025 | Direct | |||
| Bridget A. Martell | ACHV | Stock Option (right to buy) | Award | 31,500 | 31,500 | 06 Jun 2025 | Direct | |||
| Thomas B. King | ACHV | Stock Option (right to buy) | Award | 31,500 | 31,500 | 06 Jun 2025 | Direct | |||
| Stuart Duty | ACHV | Stock Option (right to buy) | Award | 31,500 | 31,500 | 06 Jun 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.